# Omega Flex, Inc.: financial statements, quarterly

OFLX · Nasdaq · CIK 1317945 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/oflx.md) · [Financials](/companies/oflx/financials.md) · [Filings](/companies/oflx/filings.md) · [Insiders](/companies/oflx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/oflx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [27.5](/filings/0001493152-24-043338.md) | [28.1 d](/filings/0001493152-25-009512.md) | [25.2](/filings/0001641172-25-008286.md) | [24.6](/filings/0001493152-25-011533.md) | [24.9](/filings/0001493152-25-020342.md) | [27.0 d](/filings/0001493152-26-009876.md) | [23.3](/filings/0001493152-26-020884.md) | [25.5](/filings/0001493152-26-037685.md) | [24.2](/filings/0001493152-25-020342.md) | [25.2 d](/filings/0001493152-26-009876.md) | [23.1](/filings/0001493152-26-020884.md) | [24.1](/filings/0001493152-26-037685.md) |
| Cost of revenue | $m | [10.5](/filings/0001493152-24-043338.md) | [11.2 d](/filings/0001493152-25-009512.md) | [10.1](/filings/0001641172-25-008286.md) | [9.4](/filings/0001493152-25-011533.md) | [9.5](/filings/0001493152-25-020342.md) | [10.4 d](/filings/0001493152-26-009876.md) | [9.3](/filings/0001493152-26-020884.md) | [10.1](/filings/0001493152-26-037685.md) | [9.7](/filings/0001493152-25-020342.md) | [10.3 d](/filings/0001493152-26-009876.md) | [10.0](/filings/0001493152-26-020884.md) | [10.8](/filings/0001493152-26-037685.md) |
| Gross profit | $m | [16.9](/filings/0001493152-24-043338.md) | [17.0 d](/filings/0001493152-25-009512.md) | [15.1](/filings/0001641172-25-008286.md) | [15.2](/filings/0001493152-25-011533.md) | [15.4](/filings/0001493152-25-020342.md) | [16.6 d](/filings/0001493152-26-009876.md) | [14.1](/filings/0001493152-26-020884.md) | [15.4](/filings/0001493152-26-037685.md) | [14.6](/filings/0001493152-25-020342.md) | [14.9 d](/filings/0001493152-26-009876.md) | [13.1](/filings/0001493152-26-020884.md) | [13.2](/filings/0001493152-26-037685.md) |
| Operating income | $m | [6.9](/filings/0001493152-24-043338.md) | [6.1 d](/filings/0001493152-25-009512.md) | [5.1](/filings/0001641172-25-008286.md) | [5.3](/filings/0001493152-25-011533.md) | [5.5](/filings/0001493152-25-020342.md) | [5.8 d](/filings/0001493152-26-009876.md) | [4.1](/filings/0001493152-26-020884.md) | [4.7](/filings/0001493152-26-037685.md) | [4.2](/filings/0001493152-25-020342.md) | [4.0 d](/filings/0001493152-26-009876.md) | [2.3](/filings/0001493152-26-020884.md) | [3.1](/filings/0001493152-26-037685.md) |
| Income tax | $m | [1.7](/filings/0001493152-24-043338.md) | [1.8 d](/filings/0001493152-25-009512.md) | [1.4](/filings/0001641172-25-008286.md) | [1.4](/filings/0001493152-25-011533.md) | [1.5](/filings/0001493152-25-020342.md) | [1.5 d](/filings/0001493152-26-009876.md) | [1.1](/filings/0001493152-26-020884.md) | [1.3](/filings/0001493152-26-037685.md) | [1.1](/filings/0001493152-25-020342.md) | [1.1 d](/filings/0001493152-26-009876.md) | [0.7](/filings/0001493152-26-020884.md) | [0.9](/filings/0001493152-26-037685.md) |
| Net income | $m | [5.6](/filings/0001493152-24-043338.md) | [4.9 d](/filings/0001493152-25-009512.md) | [4.2](/filings/0001641172-25-008286.md) | [4.5](/filings/0001493152-25-011533.md) | [4.6](/filings/0001493152-25-020342.md) | [4.7 d](/filings/0001493152-26-009876.md) | [3.6](/filings/0001493152-26-020884.md) | [4.2](/filings/0001493152-26-037685.md) | [3.7](/filings/0001493152-25-020342.md) | [3.4 d](/filings/0001493152-26-009876.md) | [2.1](/filings/0001493152-26-020884.md) | [2.7](/filings/0001493152-26-037685.md) |
| Diluted EPS | $ per share | [0.55](/filings/0001493152-24-043338.md) | not reported | [0.42](/filings/0001641172-25-008286.md) | [0.45](/filings/0001493152-25-011533.md) | [0.46](/filings/0001493152-25-020342.md) | not reported | [0.35](/filings/0001493152-26-020884.md) | [0.41](/filings/0001493152-26-037685.md) | [0.37](/filings/0001493152-25-020342.md) | not reported | [0.21](/filings/0001493152-26-020884.md) | [0.27](/filings/0001493152-26-037685.md) |
| Basic EPS | $ per share | [0.55](/filings/0001493152-24-043338.md) | not reported | [0.42](/filings/0001641172-25-008286.md) | [0.45](/filings/0001493152-25-011533.md) | [0.46](/filings/0001493152-25-020342.md) | not reported | [0.35](/filings/0001493152-26-020884.md) | [0.41](/filings/0001493152-26-037685.md) | [0.37](/filings/0001493152-25-020342.md) | not reported | [0.21](/filings/0001493152-26-020884.md) | [0.27](/filings/0001493152-26-037685.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [38.0](/filings/0001493152-23-039255.md) | [46.4](/filings/0001493152-25-009512.md) | [45.3](/filings/0001493152-24-017653.md) | [45.7](/filings/0001493152-24-030000.md) | [45.9](/filings/0001493152-24-043338.md) | [51.7](/filings/0001493152-26-009876.md) | [49.2](/filings/0001641172-25-008286.md) | [50.7](/filings/0001493152-25-011533.md) | [49.4](/filings/0001493152-25-020342.md) | [53.2](/filings/0001493152-26-037685.md) | [49.8](/filings/0001493152-26-020884.md) | [47.9](/filings/0001493152-26-037685.md) |
| Current assets | $m | [74.8](/filings/0001493152-23-039255.md) | [80.2](/filings/0001493152-25-009512.md) | [77.5](/filings/0001493152-24-017653.md) | [76.5](/filings/0001493152-24-030000.md) | [80.9](/filings/0001493152-24-043338.md) | [83.6](/filings/0001493152-26-009876.md) | [80.5](/filings/0001641172-25-008286.md) | [80.7](/filings/0001493152-25-011533.md) | [81.6](/filings/0001493152-25-020342.md) | [83.0](/filings/0001493152-26-037685.md) | [79.2](/filings/0001493152-26-020884.md) | [78.7](/filings/0001493152-26-037685.md) |
| Total assets | $m | [95.6](/filings/0001493152-23-039255.md) | [100](/filings/0001493152-25-009512.md) | [99.2](/filings/0001493152-24-017653.md) | [99.6](/filings/0001493152-24-030000.md) | [103](/filings/0001493152-24-043338.md) | [106](/filings/0001493152-26-009876.md) | [103](/filings/0001641172-25-008286.md) | [103](/filings/0001493152-25-011533.md) | [104](/filings/0001493152-25-020342.md) | [105](/filings/0001493152-26-037685.md) | [101](/filings/0001493152-26-020884.md) | [101](/filings/0001493152-26-037685.md) |
| Current liabilities | $m | [15.1](/filings/0001493152-23-039255.md) | [18.1](/filings/0001493152-25-009512.md) | [14.4](/filings/0001493152-24-017653.md) | [13.4](/filings/0001493152-24-030000.md) | [15.0](/filings/0001493152-24-043338.md) | [17.4](/filings/0001493152-26-009876.md) | [14.4](/filings/0001641172-25-008286.md) | [13.8](/filings/0001493152-25-011533.md) | [14.6](/filings/0001493152-25-020342.md) | [16.0](/filings/0001493152-26-037685.md) | [13.9](/filings/0001493152-26-020884.md) | [14.0](/filings/0001493152-26-037685.md) |
| Total liabilities | $m | [18.4](/filings/0001493152-23-039255.md) | [21.4](/filings/0001493152-25-009512.md) | [19.5](/filings/0001493152-24-017653.md) | [18.9](/filings/0001493152-24-030000.md) | [20.8](/filings/0001493152-24-043338.md) | [22.7](/filings/0001493152-26-009876.md) | [19.5](/filings/0001641172-25-008286.md) | [18.8](/filings/0001493152-25-011533.md) | [19.7](/filings/0001493152-25-020342.md) | [20.9](/filings/0001493152-26-037685.md) | [18.7](/filings/0001493152-26-020884.md) | [18.9](/filings/0001493152-26-037685.md) |
| Shareholders' equity | $m | [77.0](/filings/0001493152-23-039255.md) | [78.7](/filings/0001493152-25-009512.md) | [79.6](/filings/0001493152-24-017653.md) | [80.6](/filings/0001493152-24-030000.md) | [82.0](/filings/0001493152-24-043338.md) | [83.1](/filings/0001493152-26-009876.md) | [83.3](/filings/0001641172-25-008286.md) | [84.0](/filings/0001493152-25-011533.md) | [84.2](/filings/0001493152-25-020342.md) | [84.2](/filings/0001493152-26-037685.md) | [82.9](/filings/0001493152-26-020884.md) | [82.1](/filings/0001493152-26-037685.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [2.0 d](/filings/0001493152-24-043338.md) | [11.9 d](/filings/0001493152-25-009512.md) | [2.7](/filings/0001641172-25-008286.md) | [4.4 d](/filings/0001493152-25-011533.md) | [4.0 d](/filings/0001493152-25-020342.md) | [9.8 d](/filings/0001493152-26-009876.md) | [1.6](/filings/0001493152-26-020884.md) | [5.5 d](/filings/0001493152-26-037685.md) | [2.7 d](/filings/0001493152-25-020342.md) | [7.5 d](/filings/0001493152-26-009876.md) | [0.6](/filings/0001493152-26-020884.md) | [1.8 d](/filings/0001493152-26-037685.md) |
| Capital expenditure | $m | [0.6 d](/filings/0001493152-24-043338.md) | [0.2 d](/filings/0001493152-25-009512.md) | [0.5](/filings/0001641172-25-008286.md) | [0.6 d](/filings/0001493152-25-011533.md) | [0.3 d](/filings/0001493152-25-020342.md) | [0.6 d](/filings/0001493152-26-009876.md) | [0.6](/filings/0001493152-26-020884.md) | [0.4 d](/filings/0001493152-26-037685.md) | [0.6 d](/filings/0001493152-25-020342.md) | [0.2 d](/filings/0001493152-26-009876.md) | [0.7](/filings/0001493152-26-020884.md) | [0.2 d](/filings/0001493152-26-037685.md) |
| Dividends paid | $m | [3.3 d](/filings/0001493152-24-043338.md) | [3.3 d](/filings/0001493152-25-009512.md) | [3.3](/filings/0001641172-25-008286.md) | [3.3 d](/filings/0001493152-25-011533.md) | [3.4 d](/filings/0001493152-25-020342.md) | [3.4 d](/filings/0001493152-26-009876.md) | [3.4](/filings/0001493152-26-020884.md) | [3.4 d](/filings/0001493152-26-037685.md) | [3.4 d](/filings/0001493152-25-020342.md) | [3.4 d](/filings/0001493152-26-009876.md) | [3.4](/filings/0001493152-26-020884.md) | [3.4 d](/filings/0001493152-26-037685.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [10.1](/filings/0001493152-23-039255.md) | [10.1](/filings/0001493152-24-017653.md) | [10.1](/filings/0001493152-24-030000.md) | [10.1](/filings/0001493152-24-043338.md) | [10.1](/filings/0001641172-25-008286.md) | [10.1](/filings/0001493152-25-011533.md) | [10.1](/filings/0001493152-25-020342.md) | [10.1](/filings/0001493152-26-020884.md) | [0.0](/filings/0001493152-26-037685.md) | [10.1](/filings/0001493152-25-020342.md) | [10.1](/filings/0001493152-26-020884.md) | [0.0](/filings/0001493152-26-037685.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 10,094,322 at 2026-07-31, from the cover of the [10-Q filed 2026-08-13](/filings/0001493152-26-037685.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.